INTRODUCTION
We cohabitate with trillions of bacteria that reside within our intestines and provide important beneficial metabolic and immunologic functions (1) . However, inappropriate immune responses against these bacteria have been implicated in the pathogenesis of inflammatory bowel disease (IBD) (2-4), because germ-free mice are highly resistant to many murine colitis models. Moreover, monocolonization studies of germ-free animals revealed that IBD development may be driven by specific commensal bacterial species (5) .
Tolerance to commensal bacteria is thought to depend on CD4 + regulatory T (T reg ) cells (6-8), which we have recently shown can arise via peripheral T reg (pT reg ) cell development from naïve T (T naïve ) cells in response to commensal antigens during homeostasis (9) . However, intestinal inflammation can result in the exposure of new antigens to the immune system. In murine models, effector T (T eff ) cell generation to a commensal bacterial antigen was seen during intestinal inflammation, but not homeostasis (10) . Thus, it remains unknown whether effector responses during intestinal inflammation are driven by newly exposed antigens versus the commensal antigens that normally drive T reg cell development during homeostasis. IBD is associated with marked changes in the gut microbiota, dysbiosis (11) . Dysbiosis has been hypothesized to contribute to disease pathogenesis because it is well established that different commensal bacterial species have distinct effects on the intestinal T cell population. For example, segmented filamentous bacteria (SFB) strongly induces T helper 17 (T H 17) cells in the small intestine (12) , which has now been confirmed by T cell receptor (TCR) transgenic (Tg) studies (13) . By contrast, introduction of Clostridium clusters XIVa and IV (7, 14) or altered Schaedler flora (15) markedly increased the frequency of colonic Foxp3 + T reg cells in germ-free mice. Thus, changes in the microbiome may also affect the intestinal T eff versus T reg cell population.
Here, we used TCR repertoire analysis coupled with in vivo studies of commensal-specific TCRs to address the influence of colitis-mediated dysbiosis on bacteria-specific T reg cell development. We also examined the interaction of T cells with luminal versus mucosal-associated (MA) antigens during homeostasis and colonic inflammation. Last, we assessed the impact of commensal-specific T cells during lymphopenic conditions. In summary, our data suggest that the MA pathobionts Helicobacter spp. elicit context-dependent T cell responses during homeostasis and colitis.
RESULTS

Overlap of T eff and T reg TCR antigen specificity during colitis
To address the effect of colitis on T cell responses to commensal bacteria, we examined induced models because we wanted to compare mice that started with the same microbiota. We settled on a murine model of inflammatory colitis (Fig. 1A ) (16) that incorporates 1% dextran sodium sulfate (DSS)-induced mucosal injury along with anti-interleukin-10 receptor antibody (IL10R) (15, 17) , which blocks an important immunoregulatory pathway implicated in human IBD in genome-wide association studies (18) . DSS + IL10R treatment induced colitis as evidenced by weight loss, increased colon weight/length ratio, and a marked enhancement of T eff (CD44 hi CD62L lo ) and T reg cells ( fig. S1 ). Because the combination showed a greater effect on the microbiota than did DSS or IL10R alone ( fig. S1E ), we used DSS + IL10R for subsequent experiments.
Consistent with previous reports, T naïve cells from CT2 and CT6 TCR Tg lines, which express TCRs isolated from colonic T reg cells and recognize commensal antigens (8) , showed substantial induction of Foxp3, the canonical T reg cell transcription factor, by 1 week after transfer into control immunoglobulin G (IgG)-treated mice (Fig. 1, A and B) (9) . However, in mice undergoing DSS + IL10R-mediated colitis, they skewed toward T eff cell generation (Fig. 1B and fig. S2 ). T eff cell differentiation was primarily to the T H 17 cell phenotype based on IL-17A-green fluorescent protein (IL-17A GFP ) and interferon--yellow fluorescent protein (IFN YFP ) reporters (Fig. 1C) , consistent with observations in human Crohn's disease (19) . In addition, CT2 and CT6 cells underwent extensive proliferation, as assessed by Cell Trace Violet (CTV) dilution and expanded as a fraction of total CD4 + cells (Fig. 1, D and E) . Thus, the normal tolerogenic T reg cell developmental response to commensal bacterial antigens can be redirected to a T H 17 cell effector response during experimental colitis.
To assess whether the responses of CT2 and CT6 TCR Tg cells were representative of the T cell population, we analyzed the effect of colitis on the TCR repertoire ( fig. S3, A and B, and table S1). Because the great diversity in polyclonal T cells precludes experimental analysis at the individual TCR level, we used mice in which TCR diversity is limited by a Tg fixed TCR chain (20) . Although TCR diversity is diminished, this approach allows high-throughput analysis of the TCR repertoire at the individual TCR level via sequencing of the variable TCR chains. With colitis, both T reg and T eff repertoires showed increased clonal expansion compared with controls ( fig. S3C ), consistent with a T cell response. We saw a marked increase in similarity between the T reg and T eff TCR repertoires within the cLP of individual mice during colitis compared with controls ( Fig. 2A and fig. S3D ). (A) Experimental model. Four-to 5-week-old CD45.1 specific pathogen-free (SPF) mice were administered IL10R (1 mg per mouse) on day 0 and kept on 1% DSS water for 7 days to initiate colitis. Control mice were given isotype IgG (1 mg per mouse) on day 0. Four days after initiation of colitis, congenically marked naïve CT2/CT6 Tg cells (10 5 ) were intravenously transferred and analyzed 7 days later. (B to D) Effector cell induction and expansion with colitis. Transferred TCR Tg cells from the colon lamina propria (cLP) were analyzed by flow cytometry for (B) the development of T eff (CD44 hi CD62L lo Foxp3 − ) and T reg (Foxp3 + ) markers (P = 0.000003, P = 0.0007, P = 0.0024, P = 0.0157, Student's t test; n = 10), (C) up-regulation of cytokines using IL-17A GFP and IFN YFP (P = 0.000001, P = 0.0007, P = 0.0029, Student's t test; n = 10 for CT2 and 7 for CT6), (D) proliferation indicated by CTV dilution (P = 0.000002, P = 0.00002, Student's t test; n = 10 for CT2 and 7 and 8 for CT6), and (E) expansion indicated by the in vivo frequency among the host CD4 + T cells (P = 0.00005, P = 0.0275, Student's t test; n = 10 for CT2 and 10 and 11 for CT6). Bars indicate mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. ns, not significant.
Examination of the top 25 T eff TCRs per mouse showed that many of these TCRs are also found in the T reg cell subset during colitis (Fig. 2B) , consistent with our TCR Tg studies (Fig. 1) . In control mice, the relatively low degree of overlap between the T eff and T reg cell subset within individual mice (Fig. 2, A and B, and fig. S3D ) is consistent with our previous studies (8, 21) . As before, we also observed mouse-to-mouse variability of T eff and T reg TCR repertoires between mice ( Fig. 2A and fig. S3 , D and E). To confirm the TCR repertoire analysis, we cloned T7-1 (Fig. 2C) , the most abundant TCR found in the T eff subset of colitic mice by mean percentage ( fig. S3E ). As predicted by the TCR repertoire study, analysis of adoptively transferred peripheral TCli- TCR Tg cells expressing T7-1 showed that this TCR facilitated Foxp3 induction during homeostasis but skewed toward T eff cell generation with colitis ( Fig. 2D and fig. S4 ). Thus, these data demonstrate an increased overlap between the T eff and T reg TCR repertoires during colitis that does not occur at homeostasis. Our TCR Tg data suggest that the overlap in T reg and T eff TCR usage during colitis is due to the enhanced T eff generation by clones that might normally differentiate into T reg cells (Fig. 1) . Alternatively, the overlap may arise from increased T reg cell generation by T eff TCRs during colitis. However, transfer of CBir1 Tg cells (22) into DSS + IL10R hosts showed increased T eff but not T reg cell generation ( fig.  S5 ), consistent with a previous report in the DSS model (10) . Although it remains possible that the CBir1 result in the DSS + IL10R model is not generalizable to other model systems, in conjunction with the TCR repertoire analysis, these TCR Tg studies suggest that colitis skews T cell development such that proinflammatory T eff cells often use the same TCRs as anti-inflammatory T reg cells.
Helicobacter spp. are important drivers of pT reg cell development during homeostasis The observation that certain commensal antigens can activate both T reg cells during homeostasis and T eff cells during colitis suggested that these bacterial antigens are continually presented to the adaptive immune system. This pattern is different from the CBir1 commensal antigen, which is primarily presented to T cells during colitis ( fig. S5) (10) . To address this, we assessed the in vitro reactivity of these TCRs to fecal antigen preparations presented on CD11c + dendritic cells (DCs) (8) . Although TCR activation by fecal antigen from control mice was high with T7-1 and detectable with CT2 and CT6, the degree of enhancement in TCR activation by fecal antigens from colitic mice was limited (Fig. 3A and fig. S6 ). We therefore asked whether these TCRs show more reactivity to MA antigens, which might be predicted to have greater access to the immune system via DC uptake (23), goblet-associated passages (24) , or outer membrane vesicles (25) . Both CT2 and CT6 showed marked enhancement of TCR stimulation with MA compared with luminal antigen (Fig. 3A) . We then tested additional T reg TCRs-CT1, CT7, and CT9-which we previously found to react to fecal antigens or commensal isolates in vitro (8) . Among these six colonic T reg TCRs, four showed high-level reactivity in vitro to MA compared with luminal antigen, and of these, two were enhanced by colitis (Fig. 3A) .
To confirm that the reactivity in the MA antigen preparation was dependent on the microbiota, we treated SPF mice with a broad-spectrum antibiotic combination of vancomycin, ampicillin, metronidazole, and neomycin and found that MA antigen no longer stimulated our four MA antigen-reactive T reg TCR panel (CT2, CT6, CT9, and T7-1) ( fig. S7A ). This antibiotic cocktail includes vancomycin, which has been reported to decrease T reg cell numbers and Clostridium spp. cate mean ± SEM. *P < 0.05, **P < 0.01.
(7)
. We then tested the individual antibiotics to attempt to identify the bacterial species recognized by these TCRs by correlating in vitro TCR reactivity to MA antigen with changes in the bacteria composition. Unexpectedly, these data suggested that Helicobacter spp., and not the predicted Clostridium spp. (7), were being recognized by the TCR panel. First, of the individual antibiotics, ampicillin and neomycin, but not vancomycin or metronidazole, markedly decreased the ability of MA antigen to stimulate the TCR panel compared with untreated controls (Fig. 3B) . Second, 16S ribosomal RNA (rRNA) gene sequences from the MA antigen preparations revealed that the two most frequent operational taxonomic units (OTUs) lost with ampicillin or neomycin were Helicobacter typhlonius and Helicobacter apodemus ( Fig. 3C and fig. S7B ).
To determine whether Helicobacter spp. were being directly recognized by these TCRs, we tested cultured isolates that matched the 16S rRNA sequence (Fig. 3D ). There were specific patterns of TCR reactivity, with T7-1 and CT9 recognizing both species, whereas CT2 reacted only to H. typhlonius, and CT6 to H. apodemus. Recognition of Helicobacter spp. in vitro appeared to be TCR-specific and not via a superantigen or other antigenindependent mechanism. First, each Helicobacter isolate stimulated only some, but not all, TCRs. Second, addition of antimajor histocompatibility complex (MHC) II blocked TCR activation ( fig. S7C ). Third, testing of these TCRs against multiple bacterial isolates in vitro from different genera, including Clostridium, Bifidobacterium, and Lactobacillus, failed to activate our TCR panel to the same degree as Helicobacter ( fig. S8 ). However, these TCRs could still show cross-reactivity to different bacterial species due to shared epitopes. T7-1 likely recognizes additional bacterial antigens, because it reacted to luminal antigens with high efficiency (Fig. 3A) . CT6 may also recognize other bacterial species, because vancomycin reduced CT6 response to MA antigen without a corresponding decrease in H. apodemus frequency by 16S (Fig. 3 , B and C). We have also shown previously that CT6 reacted to an uncharacterized Clostridium spp. (8) . Although the extent of bacterial crossreactivity remains to be defined, these data demonstrate that four of our six colonic T reg TCRs recognize Helicobacter spp. in vitro.
We then asked whether these Helicobacter spp. could induce TCR-specific T reg cell responses in vivo. As expected, transfer of CT2/CT6/CT9/T7-1 TCR + cells into ampicillin-treated mice to eliminate preexisting Helicobacter spp. (Fig. 3C ) resulted in little proliferation or differentiation (Fig. 4A) . However, inoculation of ampicillin-treated mice with a single Helicobacter spp. elicited robust expansion and Foxp3 up-regulation in appropriate TCR + Tg cells (Fig. 4A) . Similarly, Helicobacter-free mice obtained from Charles River Laboratories showed little ability to induce TCR-dependent proliferation or T reg cell generation, unless the appropriate Helicobacter spp. identified in vitro (Fig. 3D ) was subsequently inoculated in vivo (Fig. 4B and  fig. S9 ). Because CT2 and CT6 Tg cells were cotransferred into the same host in this experiment, it appears that these TCR clones show a high degree of specificity for individual Helicobacter strains (Fig. 4B) . Thus, these data demonstrate that Helicobacter spp. are a major driver of bacterial-specific T reg cell responses during homeostasis.
Marked changes in bacterial composition with colitis
The observation that colitis enhanced the in vitro stimulatory ability of MA antigen (Fig. 3A) , and increased the proliferation of adoptively transferred CT2 and CT6 TCR Tg cells (Fig. 1B) , suggested that there might be alterations in the colonic microbiota. We therefore analyzed the changes in the MA and luminal 16S rRNA profile with colitis. Consistent with previous reports, the bacterial composition in the lumen versus mucosa is quite distinct (Fig. 5 , A to C) (26, 27) .
In the MA preparation, we noted a high frequency of Helicobacter spp. in both control and colitic mice (Fig. 5B) , consistent with the activation and differentiation of CT2 and CT6 Tg cells in vivo under both conditions (Fig. 1) . 
Lack of T cell responses to the bloom of luminal Bacteroides species during colitis
Because Bacteroides species have been suggested to be important triggers of intestinal inflammation in other murine models (28, 29) , we asked whether the dramatic expansion of Bacteroides species in DSS + IL10R-treated mice induced strong antimicrobial T eff cell responses.
We assessed the in vivo responses of several TCRs that recognize Bacteroides strains isolated from DSS + IL10R mice in vitro, including the B. vulgatus-reactive TCR DP1 (Fig. 6A and table S2 ). These TCRs recognized Bacteroides strains through MHC II and did not respond in vitro to the Helicobacter strains tested (fig. S11, A and B). To our surprise, adoptively transferred T cells expressing these Bacteroides-reactive TCRs did not show increased proliferation, expansion, or T eff cell development in DSS + IL10R-treated mice compared with controls (Fig. 6 , B and C). Consistent with the poor expansion, very few transferred cells were recovered from the colon. The percentage of the transferred TCR-expressing cells among total CD4 + T cells was reduced during DSS + IL10R colitis (Fig. 6C) , implying that these antigens are relatively less important during colitis despite their bloom in the lumen. We confirmed in vitro that the luminal antigens for DP1 and NT2 increased with colitis ( Fig. 6D) , as predicted based on 16S rRNA sequencing (Fig. 5F ). By contrast, MA antigen showed lower stimulatory ability than luminal antigen for DP1 and NT2 even during colitis (Fig. 6D) . We also checked that the Helicobacter spp.-reactive TCRs (Fig. 3D) did not respond to these Bacteroides strains ( fig. S11C) . Although it remains possible that these Bacteroides-reactive TCR clones do not compete well in the gut or are not representative of polyclonal T cell responses to Bacteroides, these data suggest that the marked expansion of luminal Bacteroides spp. in this model of colitis does not elicit a corresponding increase in antigen-specific T cell responses. Bars indicate mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
Pathogenic potential of Helicobacter-reactive TCRs
The differentiation of colonic T reg TCRs into T eff cells during colitis ( Fig. 1) suggests that the altered T cell response to bacterial antigens may contribute to colonic inflammation. To test the pathogenic potential of these Helicobacter spp.-reactive TCRs, we adoptively transferred naïve CT6 Tg cells into Rag1 −/− hosts with or without H. apodemus inoculation. In contrast with wild-type hosts (Fig. 4) , H. apodemus drove antigen-specific T eff cell generation of CT6 Tg cells (Fig. 7A OTUs are shown (BenjaminiHochberg-adjusted: P = 0.0009, P = 0.0086, P = 0.0009, P = 0.0086, P = 0.0266, Mann-Whitney U test; n = 8). Bars indicate mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001.
and fig. S12 ) in Rag1 −/− hosts likely due to expansion in a lymphopenic environment. In line with a T eff cell response, we observed colonic inflammation in CT6-transferred hosts only in the presence of H. apodemus, as evidenced by increased colon weight/length ratio and crypt dropout in histology (Fig. 7, B and C) . Similarly, T eff cell response of CT2 Tg cells to H. typhlonius led to colonic inflammation in Rag1 −/− hosts ( fig. S13 ). We did not note major weight loss induced by these TCR Tg cells and/or Helicobacter spp. during the time frame of this experiment (fig. S13, D and E), in contrast with polyclonal T cell transfer models (30) . This could be due to limited systemic effects from a single TCR clone or differences in gut microbiota composition. Although Helicobacter spp. without T cell transfers have been reported to induce colitis in Rag-deficient mice (31-34), we did not observe inflammation caused by these two strains during the period of the experiment (Fig. 7 and fig. S13 ). Thus, these data demonstrate the potential pathological consequences of antigen-specific T eff cell expansion against gut bacteria.
Last, MA enterohepatic Helicobacter spp. in humans have been suggested to be associated with IBD (35) . We have also detected the presence of Helicobacter spp. in patients with Crohn's disease or ulcerative colitis by 16S rRNA sequencing of fecal or colonoscopy samples ( fig. S14 ). However, it remains to be established whether these Helicobacter spp. play a similar immunomodulatory role in humans, as seen in our mouse studies.
DISCUSSION
On the basis of this study of T cell responses to commensal antigens during experimental colitis, we make the following observations: First, T eff cell responses during colitis are often to commensal antigens normally presented to the immune system during homeostasis, and not to antigens normally excluded by the mucosal barrier. Second, commensal bacterial species vary widely in their ability to induce T cell responses due, in part, to their anatomic location relative to the mucosal surfaces. Third, constitutively presented antigens appear to primarily elicit T reg cell responses during homeostasis, implying that tolerance to these antigens is important to preventing colitis. Last, Helicobacter spp. are important inducers of T cell responses during homeostasis and colitis. Thus, these data suggest a model whereby T reg cell-mediated tolerance, and not T eff cell-mediated immunity, is required against commensal bacteria such as Helicobacter spp. that routinely interact with the host immune system. Our initial goal was to study the T cell response to alterations in the gut microbiota structure, also known as dysbiosis, that occurs with colitis and IBD and has been proposed to be involved in disease pathogenesis (4, 36, 37) . However, rather than observing a dominant T eff cell response to Bacteroides spp. that bloom during colitis, the major stimulators were Helicobacter spp. that routinely interact with T cells during homeostasis. These data do not exclude the possibility that dysbiosis of Bacteroides spp. may exert non-antigen-dependent effects on T cell immunity through changes in short-chain fatty acids (38) (39) (40) , polysaccharides (41) , and aryl hydrocarbon receptor ligands (42) . Furthermore, because our studies were done in SPF mice, variability in gut flora composition and strain-level differences could affect the functional outcome of specific bacteria. Nonetheless, these data suggest that dysbiosis during intestinal inflammation may not provide an important antigenspecific trigger of effector responses that contribute to colitis.
The relative inefficiency of Bacteroides spp. to induce T cell activation is correlated with their bacterial distribution because they are preferentially found in the lumen. By contrast, MA Helicobacter spp. were potent stimulators of T cell response. This is consistent with a recent study of SFB showing that tight attachment to the intestinal epithelium plays an important role in eliciting T H 17 cells (43) . Thus, understanding the adaptive immune response to commensal bacteria may be facilitated by analysis of MA or epithelial-associated, and not luminal, bacteria.
The recognition that Helicobacter spp. are important inducers of antigen-specific T reg cells during homeostasis is consistent with a previous study (44) and suggests that our current notion of T reg -inducing bacteria as being "good bacteria" that are protective against colitis may be incomplete (7, 45) . Helicobacter spp. are widely prevalent in mice colonies around the world (46) and have often been thought of as pathobionts based on their ability to induce or enhance colitis in lymphopenic mice (32) (33) (34) or mice deficient in critical immunoregulators such as IL-10 (31, 47, 48) . To reconcile these different observations regarding Helicobacter spp., our data suggest that T cell development is context-dependent, which is tolerogenic during homeostasis and inflammatory during lymphopenia or experimental colitis. A final implication of this study is that T cell-mediated intestinal inflammation may be driven by bacteria that are always in contact with the adaptive immune system, rather than species that are mostly excluded from being presented to T cells during homeostasis. This contrasts with a previous study of CBir1 TCR Tg cells, which recognize a commensal bacteria-expressed flagellin (49) that is presented . The number of crypts observed per 100 m of ascending colon was averaged from five fields. Decreased crypt number reflects crypt dropout due to inflammation. Bars indicate mean ± SEM. **P < 0.01, ***P < 0.001, ****P < 0.0001.
to the immune system primarily during inflammation (10) . In this case, the CBir1 antigen is normally not seen by the immune system and might be considered a pathogen when seen in the context of inflammation. However, in the DSS + IL10R model of colitis, this type of immune response to commensal antigens appears to be less relevant. Thus, our studies bring up an interesting question, that is, to what extent is the human intestinal inflammatory T cell response directed toward commensal antigens that the host is commonly in contact with, that is, akin to "self" antigens, or commensal antigens that are only presented during injury, that is, "foreign" antigens.
MATERIALS AND METHODS
Study design
Animal experiments were performed in an SPF facility in accordance with the guidelines of the Institutional Animal Care and Use Committee at the Washington University. Host mice were housed together and interbred to maintain microbial integrity. Gender-matched littermate host mice were used for all comparisons. Cages were randomly assigned into different treatment groups. Both male and female mice were used. All in vivo and in vitro experiments were performed independently at least two times unless otherwise stated.
Mice CT2, CT6 (8, 9) , and DP1 Tg mice were generated as described (50) IRES-GFP CD45.1 (JAX #006772) mice. All mice were on a C57BL/6 genetic background.
Reagents, antibodies, and flow cytometry IL10R blocking antibody (BE0050), isotype IgG1 (BE0088), and anti-MHC II antibody (BE0108) were purchased from Bio X Cell. Fluorescently conjugated antibodies were purchased from BioLegend, eBioscience, and Becton Dickinson. Samples were analyzed using a FACSAria IIu (Becton Dickinson), and data were processed with FlowJo (Treestar).
Cell isolation from the cLP Cells were isolated as described (9) . Colonic segments were treated with RPMI containing 3% fetal bovine serum and 20 mM Hepes (HyClone) with dithiothreitol (DTT) (Sigma) and EDTA (Thermo Fisher) for 20 min at 37°C with constant stirring. Tissue was further digested with Liberase TL (28.3 g/ml) (Roche) and deoxyribonuclease I (200 g/ml) (Roche), with continuous stirring at 37°C for 30 min. Digested tissue was forced through a Cellector tissue sieve (Bellco Glass) and passed through a 40-m cell strainer.
T cell hybridoma stimulation assay T cell hybridoma cells expressing GFP under NFAT promoter (55) were retrovirally transduced with TCR chains of interest, as previously described (8) 
Antigen preparations
Total colonic lumen contents were collected from longitudinally opened colon and cecum, diluted with phosphate-buffered saline (PBS) (HyClone), vortexed, filtered through a 40-m strainer, and autoclaved. For MA preparation, lumen contents were removed with forceps, and the remaining tissue was rinsed with PBS. MA particles were released from colonic tissues using PBS with DTT (1 M/ml) and EDTA (5 M/ml) for 20 min at 37°C with constant stirring, followed by PBS with EDTA (2 M/ml) for three times. From each of these steps, MA particles were filtered through a 40-m strainer. Larger particles such as cells were removed by centrifugation at 1500 rpm for 10 min. The remaining particles in suspension were pelleted at 2500 rpm for 15 min, resuspended in PBS, and then autoclaved. For bacterial isolates, in vitro cultures were pelleted at 2500 rpm for 15 min, washed twice with PBS, resuspended in PBS, and autoclaved for 45 min. ) and activated in vitro with soluble anti-CD3 (0.1 g/ml; 145-2C11, Bio X Cell) and anti-CD28 (1 g/ml; 37.51, Bio X Cell) in tissue culture plates coated with rabbit antibody to hamster IgG (127-005-099, Jackson ImmunoResearch) in the presence of anti-cytokine antibodies from Bio X Cell: anti-transforming growth factor- (20 g/ml; catalog no. BE0057), anti-IFN (5 g/ml; catalog no. BE0054), anti-IL-4 (5 g/ml; catalog no. BE0045), and anti-IL-12 (5 g/ml; catalog no. BE0052). One day after activation, cells were retrovirally transduced with individual TCR chain of interest (8) 
Adoptive transfer experiments
Antibiotic treatment
Littermates were divided and treated at 3 weeks of age. Vancomycin (0.5 mg/ml), ampicillin (1 mg/ml), and neomycin (1 mg/ml) were administrated ad libitum via drinking water continuously for the time indicated. Metronidazole (1 mg/ml) was administrated by oral gavage every day for 1 week followed by gavage every other day (56) .
Bacterial isolation, culture, and inoculation
Colonic lumen contents from DSS + IL10R-treated mice were homogenized, and serial dilutions were plated on brain heart infusion (BHI; BD Difco) agar supplemented with 10% (v/v) defibrinated horse blood (Colorado Serum Co. IRES-Thy1.1 TCR +/− mice using BD FACSAria IIu. TCR complementary DNA synthesis from purified cells was performed as described (57) . A two-step polymerase chain reaction (PCR) was used to amplify multiple TRAV (TCR  variable) genes (multiplex PCR; table S1) (58) . Amplicons were purified after each PCR using the Agencourt AMPure XP magnetic purification system. The ~200-to 600-base pair (bp) amplicons were quantified using the Qubit dsDNA BR Assay Kit (Invitrogen) and pooled in equimolar ratios for 250-bp paired-end sequencing using Illumina MiSeq at the Washington University Genome Sequencing Center. Sequences were demultiplexed and analyzed using blastn to identify the TRAV and TRAJ (TCR  joining) gene segments using the IMGT database (59) . This information was then used to determine the CDR3 sequence. A unique TCR is identified by its TRAV and CDR3 amino acid sequence. Frequency filtering was applied to keep TCRs >0.1% of raw data in at least one sample. TRAVs with a frequency below 1% of the total population in multiplex PCR were excluded to limit variability from low read numbers due to low primer efficiency. The filtered TRAVs accounted for more than 76.2 ± 8.8% of the total TRAV repertoire. TRAV_CDR3 species frequencies were then multiplied by a correction factor determined by the ratio of TRAV sequences obtained using multiplex versus template switch PCR ( fig. S3B) (60) .
16S rRNA gene sequencing
Colonic lumen contents or MA preparations were processed for DNA isolation using the ISOLATE Fecal DNA Kit (Bioline). For fig. S1E , terminal pellets were homogenized with PBS and prepared for bacteria FACS and 16S rRNA sequencing as in (61) . The V4 region of 16S rRNA gene was PCR-amplified using barcoded primer described previously (62) and sequenced using the Illumina MiSeq Platform (2 × 250-bp paired-end reads). OTU picking was performed using UPARSE (usearch v.8.0.162) (63) , and taxonomy was assigned using the uclust method with the Greengenes 13.8 database (QIIME v1.9) (64).
Colon histology
Mouse colons were collected, and luminal contents were removed, cut open longitudinally, and pinned and fixed with 10% (v/v) formalin. Fixed samples were paraffin-embedded, cut into 5-m sections, and stained with H&E by standard procedures. Crypt height was measured from digital photographs of H&E-stained colon sections taken with a Nikon ECLIPSE 50i microscope.
Statistical analysis
GraphPad Prism v7, R v3.3.0, and Qiime v1.9 were used for statistical and graphical analysis. Student's t test, Mann-Whitney U test, oneway ANOVA, and two-way repeated-measures ANOVA were used for between-subjects analyses. Benjamini-Hochberg false discovery rate correction was used on Mann-Whitney U calculations for OTU comparisons. Morisita-Horn statistical test was used for TCR repertoire comparison. TCR Renyi diversity profiles were generated, as previously indicated (53), using Renyi entropy values with /order values ranging from 0 (natural logarithm of species richness) to 2 (natural logarithm of the inverse Simpson index). This includes  = 1, which represents the commonly used Shannon entropy.
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